Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Verastem Oncology shares take a nose dive after launching stock offering

Wednesday, May 16, 2018 8:09
% of readers think this story is Fact. Add your two cents.

Shares of Verastem Oncology (NASDAQ:VSTM)  took a nose dive after the cancer drug specialist revealed that it is diluting its shares by launching another share offering.

Verastem stock slumped 12% to US$4.62 after the group priced 7,777,778 shares of its common stock at US$4.50. This offering is expected to raise US$35mln on a gross basis.

Verastem, which is based in Boston, has also granted the underwriter a thirty-day window to purchase up to an additional 1,166,666 shares of its common stock, which are worth about US$5.25mln.

Cantor Fitzerald will act as the sole book-running manager for the offering, which is expected to close on May 18, subject to closing conditions.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories


Top Global

Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.